Gossamer Bio Inc (NASDAQ:GOSS)
| 2.62 Delayed Data As of 3:39pm ET |  -0.015 / -0.57%Today’s Change | 1.57 Today|||52-Week Range 15.20 | +20.51% Year-to-Date |
Latest GOSS News | Press Releases
No recent news for Gossamer Bio Inc.
Today’s Trading
| Previous close | 2.63 |
| Today’s open | 2.41 |
| Day’s range | 2.41 - 2.70 |
| Volume | 69,414 |
| Average volume (3 months) | 4,251,201 |
| Market cap | $231.5M |
Data as of 3:39pm ET, 01/31/2023
Growth & Valuation
| Earnings growth (last year) | +11.98% |
| Earnings growth (this year) | +12.09% |
| Earnings growth (next 5 years) | +7.58% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNFTGenfit SA | 0.00 | 0.00% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 2:47pm ET, 01/30/2023
Financials
| Next reporting date | March 24, 2023 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$234.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
